![Axel Ullrich](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Axel Ullrich
Gründer bei
SciRhom GmbH
Profil
Axel Ullrich is the founder of SciRhom GmbH, founded in 2016.
Dr. Ullrich was the founder of Evotec (München) GmbH, founded in 2005, and served as Member-Supervisory Board from 2005 to 2009.
Dr. Ullrich is also the founder of Sugen, Inc.,Axxima Pharmaceuticals AG,NEO New Oncology GmbH,U3 Pharma AG..
Dr. Ullrich is Director-Supervisory Board at Max-Planck-Institute for Molecular Genetics since 2009.
Former jobs include Non-Executive Director at Cryptome Pharmaceuticals Ltd. and Scientist at Genentech, Inc. from 1978 to 1988.
Aktive Positionen von Axel Ullrich
| Unternehmen | Position | Beginn |
|---|---|---|
Max-Planck-Institute for Molecular Genetics
 Max-Planck-Institute for Molecular Genetics Other Consumer ServicesConsumer Services Functions as a College/University | Direktor/Vorstandsmitglied | - |
SciRhom GmbH
 SciRhom GmbH BiotechnologyHealth Technology Operates as a pioneering biotech enterprise specialized in developing therapeutic antibodies | Gründer | 01.01.2016 |
Ehemalige bekannte Positionen von Axel Ullrich
| Unternehmen | Position | Ende |
|---|---|---|
NEO New Oncology GmbH
 NEO New Oncology GmbH Medical/Nursing ServicesHealth Services Designs and develops diagnostic platform | Gründer | 07.04.2022 |
Axxima Pharmaceuticals AG
 Axxima Pharmaceuticals AG Miscellaneous Commercial ServicesCommercial Services Researches and develops drugs | Gründer | 05.02.2009 |
Cryptome Pharmaceuticals Ltd.
 Cryptome Pharmaceuticals Ltd. BiotechnologyHealth Technology Discovers and develops effective and safe protein-derived medicines | Direktor/Vorstandsmitglied | 05.04.2006 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01.01.1988 |
Sugen, Inc.
 Sugen, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs and related pharmaceutical products | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
69
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Sugen, Inc.
Sugen, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs and related pharmaceutical products | Health Technology |
Cryptome Pharmaceuticals Ltd.
Cryptome Pharmaceuticals Ltd. BiotechnologyHealth Technology Discovers and develops effective and safe protein-derived medicines | Health Technology |
Axxima Pharmaceuticals AG
Axxima Pharmaceuticals AG Miscellaneous Commercial ServicesCommercial Services Researches and develops drugs | Commercial Services |
U3 Pharma AG
 U3 Pharma AG Miscellaneous Commercial ServicesCommercial Services Researches and develops novel targeted therapeutics used for cancer treatment | Commercial Services |
Max-Planck-Institute for Molecular Genetics
Max-Planck-Institute for Molecular Genetics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Evotec (München) GmbH
 Evotec (München) GmbH Chemicals: Major DiversifiedProcess Industries Provides manufacturing and research support services for pharmaceutical and biotechnology companies | Process Industries |
NEO New Oncology GmbH
NEO New Oncology GmbH Medical/Nursing ServicesHealth Services Designs and develops diagnostic platform | Health Services |
SciRhom GmbH
SciRhom GmbH BiotechnologyHealth Technology Operates as a pioneering biotech enterprise specialized in developing therapeutic antibodies | Health Technology |
Wählen Sie MarketScreener 
